Inhibitory effects of endocannabinoid on the action potential of pacemaker cells in sinoatrial nodes of rabbits / 生理学报
Acta Physiologica Sinica
; (6): 129-134, 2013.
Article
Dans En
| WPRIM
| ID: wpr-333125
Responsable en Bibliothèque :
WPRO
ABSTRACT
Endocannabinoid anandamide (AEA) has protective effect on the heart against ischemia/reperfusion injury and arrhythmia, but the electrophysiological mechanism is unclear yet. In this study, the sinoatrial node (SAN) samples from New Zealand rabbits were prepared, and intracellular recording technique was used to elucidate the effect of AEA on the action potential (AP) of SAN pacemaker cells of rabbits and the mechanism. Different concentrations of AEA (1, 10, 100, 200, 500 nmol/L) were applied cumulatively. For some SAN samples, cannabinoid type 1 (CB1) receptor antagonist AM251, cannabinoid type 2 (CB2) receptor antagonist AM630, potassium channel blocker tetraethylammonium (TEA) and nitric oxide (NO) synthase inhibitor L-nitro-arginine methylester (L-NAME) were used before AEA treatment, respectively. We found that (1) AEA (100, 200 and 500 nmol/L) not only shortened AP duration (APD), but also decreased AP amplitude (APA) (P < 0.05). (2) AM251, but not AM630, abolished the effect of AEA on APD shortening. (3) TEA and L-NAME had no influence on the AEA effect. These findings suggest that anandamide can decrease APA and shorten APD in SAN pacemaker cells of rabbits, which may be mediated by activation of CB1 receptors, and is related to blockade of calcium channels but not potassium channels and NO.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Pharmacologie
/
Pipéridines
/
Pyrazoles
/
Noeud sinuatrial
/
Potentiels d'action
/
Acides arachidoniques
/
L-NAME
/
Biologie cellulaire
/
Inhibiteurs des canaux potassiques
/
Myocytes cardiaques
Limites du sujet:
Animals
langue:
En
Texte intégral:
Acta Physiologica Sinica
Année:
2013
Type:
Article